This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chen, E. I. Articles by Felding-Habermann, B. Search for Related Content PubMed PubMed Citation Articles by Chen, E. I. Articles by Felding-Habermann, B.

Adaptation of Energy Metabolism in Breast Cancer Brain Metastases

Departments of ¹ Cell Biology and ² Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California and ³ Nutritional Biochemistry, Interdisciplinary Research Center, Justus-Liebig University Giessen, Giessen, Germany

Requests for reprints: Emily I. Chen, E-mail: emilyc{at}scripps.edu; or Brunhilde Felding-Habermann, Department of Molecular and Experimental Medicine, Scripps Research Institute, MEM 175, La Jolla, CA 92037. Phone: 858-784-2021; Fax: 858-784-2030; E-mail: brunie{at}scripps.edu.

Brain metastases are among the most feared complications in breast cancer, as no therapy exists that prevents or eliminates breast cancer spreading to the brain. New therapeutic strategies depend on specific knowledge of tumor cell properties that allow breast cancer cell growth within the brain tissue. To provide information in this direction, we established a human breast cancer cell model for brain metastasis based on circulating tumor cells from a breast cancer patient and variants of these cells derived from bone or brain lesions in immunodeficient mice. The brain-derived cells showed an increased potential for brain metastasis in vivo and exhibited a unique protein expression profile identified by large-scale proteomic analysis. This protein profile is consistent with either a selection of predisposed cells or bioenergetic adaptation of the tumor cells to the unique energy metabolism of the brain. Increased expression of enzymes involved in glycolysis, tricarboxylic acid cycle, and oxidative phosphorylation pathways suggests that the brain metastatic cells derive energy from glucose oxidation. The cells further showed enhanced activation of the pentose phosphate pathway and the glutathione system, which can minimize production of reactive oxygen species resulting from an enhanced oxidative metabolism. These changes promoted resistance of brain metastatic cells to drugs that affect the cellular redox balance. Importantly, the metabolic alterations are associated with strongly enhanced tumor cell survival and proliferation in the brain microenvironment. Thus, our data support the hypothesis that predisposition or adaptation of the tumor cell energy metabolism is a key element in breast cancer brain metastasis, and raise the possibility of targeting the functional differentiation in breast cancer brain lesions as a novel therapeutic strategy. [Cancer Res 2007;67(4):1472–86]